EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists

Cian O'Mahony, Kieran Dalton, Leon O'Hagan, Kevin D Murphy, Clare Kinahan, Emma Coyle, Laura J Sahm, Stephen Byrne, Ciara Kirke

International Journal of Clinical Pharmacy · 2024

DOI: 10.1007/s11096-024-01732-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, 2024. Verfasst von Cian O'Mahony und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Pharmacists, Patient-Centered Care. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union INTERREG VA, University College Cork.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medicines reviews by general practice pharmacists improve patient outcomes, but little is known about the associated economic outcomes, particularly in patients at higher risk of medicines-related harm.

Aim

To conduct an economic cost-benefit analysis of pharmacists providing person-centred medicines reviews to patients with hyperpolypharmacy (prescribed ≥ 10 regular medicines) and/or at high risk of medicines-related harm across multiple general practice settings.

Method

Service delivery costs were calculated based on the pharmacist’s salary, recorded timings, and a general practitioner fee. Direct cost savings were calculated from the cost change of patients’ medicines post review, projected over 1 year. Indirect savings were calculated using two models, a population-based model for avoidance of hospital admissions due to adverse drug reactions and an intervention-based model applying a probability of adverse drug reaction avoidance. Sensitivity analyses were performed using varying workday scenarios.

Results

Based on 1471 patients (88.3% with hyperpolypharmacy), the cost of service delivery was €153 per review. Using the population-based model, net cost savings ranging from €198 to €288 per patient review and from €73,317 to €177,696 per annum per pharmacist were calculated. Using the intervention-based model, net cost savings of €651–€741 per review, with corresponding annual savings of €240,870–€457,197 per annum per pharmacist, were calculated. Savings ratios ranged from 181 to 584% across all models and inputs.

Conclusion

Person-centred medicines reviews by general practice pharmacists for patients at high risk of medicines-related harm result in substantial cost savings. Wider investment in general practice pharmacists will be beneficial to minimise both patient harm and healthcare system expenditure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisPharmacistsPatient-Centered CareHumansGeneral PracticePolypharmacyProfessional RoleDrug-Related Side Effects and Adverse ReactionsMaleFemaleAged

Stichwörter der Autor:innen

CostGeneral practicePharmacistPharmacoeconomicsPolypharmacy

Autor:innen und Institutionen

  • Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland.
  • Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland. kieran.dalton@ucc.ie.
  • Primary Care, Community Healthcare Organisations 1 and 8, Health Service Executive, Dublin, Ireland.
  • National Quality and Patient Safety Directorate, Health Service Executive, Dublin, Ireland.

Förderung

  • European Union INTERREG VA
  • University College Cork

Zitieren

APA

O'Mahony, C., Dalton, K., O'Hagan, L., Murphy, K. D., Kinahan, C., Coyle, E., Sahm, L. J., Byrne, S., & Kirke, C. (2024). Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01732-y

Vancouver

O'Mahony C, Dalton K, O'Hagan L, Murphy KD, Kinahan C, Coyle E, et al. Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists. International Journal of Clinical Pharmacy. 2024. doi:10.1007/s11096-024-01732-y

BibTeX
@article{OMahony2024,
  author = {O'Mahony, Cian and Dalton, Kieran and O'Hagan, Leon and Murphy, Kevin D and Kinahan, Clare and Coyle, Emma and Sahm, Laura J and Byrne, Stephen and Kirke, Ciara},
  title = {Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists},
  journal = {International Journal of Clinical Pharmacy},
  year = {2024},
  doi = {10.1007/s11096-024-01732-y}
}
Kostenlos starten →